NKGen Biotech to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
SANTA ANA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK natural killer (“NK”) cell therapies, today announced that its Executive Leadership will present at the Cantor Fitzgerald 2023 Global Healthcare Conference on Wednesday, September 27, 2023, in New York City. Please see details below:
Cantor Fitzgerald Global Healthcare Conference
The webcast will be accessible on the Events & Presentations page in the Investors section of the Company’s website at www.nkgenbiotech.co beginning on the day of the event.
Grand Opening Reception in Expo Hall
Leading on CX Transformation: Best Practices for Proven Success
The Value of A/V Technology to Successful Communications